A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure
Clinical trial NCT00260923 · COMPLETED
Trial details
- NCT number
- NCT00260923
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2006-11-01
- Enrollment
- 641
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.